Event Brief
Feb 9, 2026 at 3:03 PM ET
FDA Flags Novo Nordisk's Obesity Pill Ad for Misleading Claims
By The BriefBrief
FDA demands Novo Nordisk address misleading claims in TV ads for obesity medication.
WHO: FDA, Novo Nordisk
WHAT: Misleading advertising claims
WHEN: Feb 9, 2026 at 2:18 PM ET
WHERE: USA
WHY: To ensure accurate information about the obesity pill
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 21452 of 21451
Same format. Every time.
Continue reading — sign in or create a free account with
